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Helicobacter pylori causes diseases ranging from gastritis to peptic ulcer disease to gastric cancer. Geograph-
ically, areas with high incidences of H. pylori infection often overlap with areas with high incidences of gastric
cancer, which remains one of the leading causes of cancer-related deaths worldwide. Strains of H. pylori that
carry the virulence factor cytotoxin-associated gene A (cagA) are much more likely to be associated with the
development of gastric cancer. Moreover, particular C-terminal polymorphisms in CagA vary by geography
and have been suggested to influence disease development. We conducted a large-scale molecular epidemiologic
analysis of South Korean strains and herein report a statistical link between the East Asian CagA EPIYA-ABD
genotype and the development of gastric cancer. Characterization of a subset of the Korean isolates showed
that all strains from cancer patients expressed and delivered phosphorylatable CagA to host cells, whereas the
presence of the cagA gene did not strictly correlate to expression and delivery of CagA in all noncancer strains.
Helicobacter pylori is a medically important pathogen, and
although infection rates vary geographically, this bacterium
colonizes more than 50% of the world’s population globally
(20, 28). This spiral-shaped, gram-negative, and microaero-
philic bacterium chronically inhabits the unforgiving environ-
ment of the stomach and causes subclinical gastritis in the
majority of patients. However, in some individuals, H. pylori
colonization results in peptic ulcer disease; 75% of gastric
ulcers and 90% of duodenal ulcers are attributed to H. pylori
infection (19). At its most severe sequelae, H. pylori infection
can lead to the development of two forms of gastric cancer,
adenocarcinoma and mucosa-associated lymphoid tissue lym-
phoma (11, 33, 34, 43). The association of H. pylori with stom-
ach cancer led the World Health Organization to classify it as
a class I carcinogen in 1994 (26). It currently remains the only
bacterium to have obtained this perilous distinction.
Gastric cancer is the second most common cause of cancer
deaths worldwide, and this fact could be reflective of the high
incidence of H. pylori infection (18, 30, 32, 47). Interestingly,
geographic areas with the highest levels of gastric cancer,
which include most East Asian countries, also have the highest
rates of H. pylori infection (1, 18, 47). Additionally, in East
Asian countries, 90% of strains carry the cytotoxin-associated
gene A (cagA) (27), which has emerged as a major contributor
to disease severity. In fact, cagA-positive H. pylori strains are at
least twice as likely to cause cancer as H. pylori strains without
cagA (12, 22).
cagA is carried on the cag pathogenicity island (PAI), which
carries genes that produce a type IV secretion apparatus that
is used to directly inject CagA into host cells (15). Within the
cells, CagA is phosphorylated by host cell kinases, forms a
complex with SHP-2 (Src homology region 2-containing phos-
phatase 2) (25), and alters multiple host signaling pathways
(23–25, 29, 36, 46). The phosphorylation of CagA occurs in the
carboxy terminus of conserved tyrosine residues that are part
of a repeated five-amino-acid sequence (Glu-Pro-Ile-Tyr-Ala)
referred to as the EPIYA motif (24, 25).
Initial studies showed that CagA proteins from various H.
pylori isolates migrated differently on denaturing gels (17). It
was subsequently shown that a number of cagA alleles exist and
that variation in the carboxy terminus of the protein is the
major difference between the different alleles. Polymorphisms
in the C terminus occur in the EPIYA region and typically
involve changes in the amino acid sequences flanking the five-
amino-acid repeat. The most-common motifs have been des-
ignated EPIYA-A, -B, -C, and -D (24) and are found in two
distinct combinations by geographic location. Western CagA
consists of a combination of EPIYA-A, -B, and -C motifs (up
to five EPIYA-C motifs have been identified), whereas East
Asian CagA contains a combination of EPIYA-A, -B, and -D
motifs (4, 17, 24, 25, 31, 42).
EPIYA-C and -D serve as the primary CagA phosphoryla-
tion sites and are required for binding to SHP-2 (24). Among
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Western isolates, molecular epidemiological studies have indi-
cated a correlation between disease severity and an increased
number of EPIYA-C motifs (5, 24, 48). Indeed, in cases where
Western strains are associated with cancer, most have multiple
EPIYA-C motifs (8, 39). This increase may be due to elevated
morphological transformation as a result of increased CagA
phosphorylation and SHP-2 binding (24).
East Asian CagA containing the EPIYA-D motif demon-
strates higher affinity for SHP-2 than Western CagA. This
leads to greater morphological changes in infected cells (24) as
well as greater levels of inflammation and atrophy (9). These
findings, along with the fact that East Asian strains predomi-
nate in countries with the highest rates of gastric cancer, sug-
gest that East Asian CagA may have the potential to induce
more-severe forms of gastric disease (1, 18, 47).
In order to assess the correlation between the cagA genotype
and H. pylori-induced disease severity, we examined a collec-
tion of isolates from South Korea, which has one of the highest
rates of H. pylori colonization (44) and one of the highest rates
of gastric cancer in the world (22, 41). Additionally, the ma-
jority of South Korean strains carry the East Asian cagA allele
(16). Here, we present molecular epidemiologic evidence that
there is a significant association between the development of
gastric cancer and infection with H. pylori strains carrying the
EPIYA-ABD genotype.
MATERIALS AND METHODS
Bacterial strains. Korean bacterial strains along with G27-MA (2), and its
isogenic derivatives G27-MA cagA (3) and G27-MA PAI (provided by Man-
uel Amieva and constructed as described in Galgani et al. [21]), were cultured as
previously described (14). Briefly, bacterial stocks preserved at 80°C were
grown and expanded on antibiotic-supplemented horse blood agar plates. Over-
night liquid cultures, consisting of brucella broth (BB) (Acumedia, Lansing, MI)
containing 10% fetal bovine serum (Invitrogen, Carlsbad, CA) and 10 g/ml
vancomycin (Amresco, Solon, OH), were subcultured to an optical density at 600
nm of 0.05 in fresh media and were grown for 18 h under microaerophilic
conditions created by an Anoxomat evacuation/replacement system (Spiral Bio-
tech, Norwood, MA).
Clinical isolate acquisition. Isolates were obtained from patients presenting
with gastric symptoms to the Division of Gastroenterology in the Department of
Internal Medicine at the College of Medicine of the Catholic University of Korea
in Seoul, Korea. Written informed consent was received from each patient, and
the protocol was approved by the Institutional Review Board of Human Re-
search at the Catholic University of Korea. Biopsy samples were collected at the
site of visible mucosal disturbance, and histology was performed to provide a
diagnosis along with culture for the presence of gram-negative, spiral-shaped
bacteria that produced a functional urease enzyme. Subsequently, a single-colony
isolate was selected from each biopsy sample for further characterization. An
extensive breakdown of the epidemiological characteristics of the patients can be
found in Table 1, and a complete list of strains is available in Table S1 in the
supplemental material. Strains are named such that the letters following the
strain number indicate the disease state as follows: cancer (-CA), duodenal ulcer
(-DU), gastritis (-G), and gastric ulcer (-GU).
cagA genotyping. All the primers used in this study are listed in Table 2.
Genomic DNA was extracted using the Easy-DNA kit (Invitrogen, Carlsbad,
CA), and genotyping of the C terminus of cagA was performed by PCR using a
modified version of the strategy developed by Argent et al. (7), as schematically
depicted in Fig. 1A and B and Fig. S1 in the supplemental material. Briefly,
amplification with primers cagA28F or cag2 and cagA-P1C or cagA-pA-1 (R)
identifies an EPIYA-A motif. Amplification with primers cagA28F or cag2 and
a 1:1 mixture of primers cagA-P2TA and cagA-P2CG indicates an EPIYA-B
motif. Amplification using primers cagA28F or cag2 and cagA-P3E identifies the
presence of either an EPIYA-C motif or an EPIYA-D motif, and an additional
amplicon with cagA28F or cag2 and the unique cagA-pD (R) primer categorizes
CagA as having an EPIYA-D motif. In some cases where the PCR amplification
was inconclusive and to confirm results of the PCR genotyping, cagA was am-
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plified with cag2 and either cagA seq (R) or grace2 (which lies within the
downstream conserved glutamate racemase gene) and then sequenced using
primers cag2 and cagA seq (R). Sanger dideoxy sequencing was performed at the
Uniformed Services University of the Health Science Biomedical Instrumenta-
tion Center (Bethesda, MD) or at Cosmo Genetech Co., Ltd (Seoul, Korea). The
resulting DNA sequences were analyzed using Vector NTI version 9.1 (Invitro-
gen) and Sequencher 4.5 (Gene Codes Corp., Ann Arbor, MI).
CagA protein expression. After 24 hours, lawns of bacteria were harvested
from horse blood agar plates, pelleted, resuspended in 1 phosphate-buffered
saline (PBS), and mixed with 5 Laemmli sample buffer. Bacterial lysates were
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, using a
10% separating gel and a 4% stacking gel, and proteins were transferred to
nitrocellulose membranes using a semidry transfer apparatus (Owl; Thermo
Scientific, Rochester, NY). Membranes were probed with a 1:5,000 dilution of
mouse immunoglobulin G1 (IgG1) anti-CagA monoclonal antibody (Austral
Biologicals, San Ramon, CA), followed by a 1:20,000 dilution of horseradish
peroxidase (HRP)-conjugated goat anti-mouse IgG secondary antibody (Santa
Cruz Biotechnology, Santa Cruz, CA). Alternatively, membranes were probed
with a 1:5,000 dilution of rabbit IgG anti-CagA polyclonal antibody b-300 (Santa
Cruz Biotechnology), followed by a 1:20,000 dilution of HRP-conjugated bovine
anti-rabbit IgG secondary antibody (Santa Cruz Biotechnology). Proteins were
detected using the Pierce ECL Western blotting substrate kit (Thermo Scientific/
Pierce, Rockford, IL) and photographic film with a Series XXXV A rapid
processor (S&W Imaging, Frederick, MD) or using the SuperSignal West Pico
chemiluminescent substrate kit (Thermo Scientific/Pierce) and a LAS-3000
Intelligent Dark Box with LAS-3000 Lite capture software (Fujifilm, Stam-
ford, CT).
CagA phosphorylation assays. The CagA phosphorylation assays were essen-
tially conducted as previously described (13). Briefly, six-well tissue culture plates
were seeded with 3.5  105 AGS cells per well and allowed to grow for 3 days in
normal cell culture media, Dulbecco’s modified Eagle’s media without L-glu-
tamine (Quality Biological, Inc., Gaithersburg, MD), supplemented with 10%
fetal bovine serum, 10 g/ml vancomycin, and 2 nM L-glutamine (Quality Bio-
logical, Inc.). Two hours prior to infection, AGS cells were washed with 1 PBS,
and 3 ml of fresh media was added to each well. Liquid cultures of H. pylori were
resuspended in 1 ml of 1 PBS and used to infect the AGS cells at a multiplicity
of infection (MOI) of 100. Infections were allowed to proceed for 5 h, at which
point the media was removed, and the cells were washed with 1 PBS and lysed
with 5 Laemmli sample buffer. Infected cell lysates were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis, using a 6% separating gel
and a 4% stacking gel. Proteins were transferred to nitrocellulose membranes by
semidry transfer. Membranes were then probed with a 1:5,000 dilution of an
anti-phospho-tyrosine monoclonal antibody, pY100 (Cell Signaling Technology,
Danvers, MA), followed by a 1:20,000 dilution of HRP-conjugated goat anti-
mouse IgG secondary antibody and detection as described above. Membranes
were subsequently stripped (using a heated 10-mM dithiothreitol solution) and
reprobed with the polyclonal anti-CagA antibody b-300 as described above.
Densitometry was performed using MultiGauge software (Fujifilm).
A low level of cross-reactivity for CagA with the anti-phospho-tyrosine anti-
bodies (pY100 and pY99; BD Biosciences, San Jose, CA) was observed. Hence,
bacterial lysates were run adjacent to their corresponding infected cell lysates so
that any cross-reactivity could be accounted for when comparing the ratio of
phosphorylated CagA to that of total CagA for infected cell lysates (Table 3).
Cell elongation studies. The cell elongation studies were essentially conducted
as previously described (13). Six-well tissue culture plates were seeded with 2.7
105 AGS cells per well and allowed to grow in normal cell culture media for 22 h.
After 22 h and approximately 2 h before infection, the media was removed, the
cells were washed with 1 PBS, and 1 ml of fresh cell culture media supple-
mented with 10% BB was added to each well. Eighteen-hour liquid cultures of H.
pylori that were suspended in 1 ml of the BB-supplemented cell culture media
were then used to infect cells at an MOI of 100. Infections were allowed to
proceed for 9 hours, at which point cells were fixed with 2% paraformaldehyde
in 100 mM phosphate buffer (pH 7.4) and stained with Giemsa (Sigma-Aldrich,
Inc., St. Louis, MO) per the manufacturer’s directions. Cells were analyzed using
an Olympus BX60 (Olympus America Inc., Center Valley, PA) and were digitally
photographed using a Spot RT color camera (Diagnostic Instruments, Sterling
Heights, MI). One hundred cells were counted to assess the number of cells
displaying the hummingbird phenotype, which is characterized by the presence of
fingerlike protrusions (40). In each case, the infections and analysis were repli-
cated to verify the reproducibility of the results. Any strain that on average
induced more than 60% of the AGS cells to display the hummingbird phenotype
in biologically independent experiments was considered positive for the presence
of a functional CagA.
IL-8 induction assay. Six-well tissue culture plates were seeded with 4.2  105
AGS cells per well and allowed to grow in normal cell culture media for 24 h. At
this point, the media was removed and replaced with media lacking serum for a
period of 24 h before H. pylori infection. Approximately 2 hours prior to infec-
tion, the cells were washed with 1 PBS, and 1 ml of fresh media without serum
was added to each well. Eighteen-hour liquid cultures of H. pylori were pelleted
and resuspended in 700 l of cell culture media without serum and used to infect
the semiconfluent AGS cells at an MOI of 100. After 5 hours, the cell culture
supernatant was collected, samples were centrifuged at 16,100 relative centrifu-
gal force for 10 min, and the supernatant was transferred to a new tube and
stored at 20°C until later use. Human interleukin-8 (IL-8) concentration was
measured using an enzyme-linked immunosorbent assay kit (R&D Systems,
Minneapolis, MN) by following the manufacturer’s directions. The change in
IL-8 concentration was calculated in comparison to that of G27-MA PAI. An
independent biological repeat of each infection was conducted, and strains were
considered to induce IL-8 if the average change was more than 10-fold.
Statistical analysis. The Fisher exact test was used to analyze the association
between disease state and EPIYA motif genotype. Log linear modeling was used
to assess whether this association was consistent across the age and sex sub-
groups. We fit a saturated model using categorical variables representing geno-
type, disease state, sex, and age groups. A backward selection algorithm identi-
fied two- and three-way associations among these variables that were statistically
significant at the 5% level. Data were analyzed using SPSS version 14 software
(SPSS Inc., Chicago, IL).
Nucleotide sequence accession numbers. The sequences for the C-terminal
region of CagA from 47 strains have been deposited in GenBank under accession
numbers FJ458117 to FJ458163.
RESULTS
Sample acquisition/cagA genotyping. A total of 260 H. pylori
clinical isolates were obtained from patients presenting with
gastric maladies (Table 1). Six of these were missing the epi-
demiological data of age and gender. Of the remaining 254, the
mean patient age was 51 years, with an age range of 14 to 86
years. There were 126 females (49.6%), with a mean age of 52
years and an age range of 21 to 86 years, and 128 males
(50.4%), with a mean age of 50 years and an age range of 14 to
82 years. Of the 254 samples, 45.3% were from patients with
gastritis, 43% from patients with ulcers (21.7% gastric ulcers
and 21.3% duodenal ulcers), and 11.8% from patients with
cancer.
Four different PCRs were conducted for each strain in order
to genotype cagA (Fig. 1A and B; see Fig. S1 in the supple-
mental material). As previously described, three of these PCRs
identify different EPIYA motifs; one identifies the EPIYA-A
motif, one the EPIYA-B motif, and one an EPIYA-C or
EPIYA-D motif (7). To definitively identify the EPIYA-D
motif, we also designed and employed primer cagA-pD (R),
which is well conserved among strains carrying the EPIYA-D
motif and was one of the first primers designed to specifically
TABLE 2. Primer sequences
Primer Sequence (5–3) Referenceor source
cag2a GGAACCCTAGTCGGTAATG 37
cagA28F TTCTCAAAGGAGCAATTGGC 8
cagA-P1C GTCCTGCTTTCTTTTTATTAACTTKAGC 8
cagA-pA-1 (R) CTTGTCCTGYTTTCTTTTTATTAAC This study
cagA-P2TA TTTAGCAACTTGAGTATAAATGGG 8
cagA-P2CG TTTAGCAACTTGAGCGTAAATGGG 8
cagA-P3E ATCAATTGTAGCGTAAATGGG 8
cagA-pD (R) TTGATTTGCCTCATCAAAATC This study
cagA seq (R)a TGGTTGAATCCAATTTTATC This study
grace2 TCATGCGAGCGGCGATGT This study
a This primer was also used for sequencing.
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amplify the EPIYA-D motif. Using this technique, we were able
to genotype 234 strains (Table 1). These strains displayed the
same age ranges as the full collection and a had mean age of 50
years. Again, the proportion of females (112) to males (116) was
virtually identical to that of the larger collection, 49.1% to 50.9%,
respectively. The remaining 26 strains, which all came from non-
cancer patients, failed to yield PCR products or gave incorrectly
sized bands and thus were not further analyzed.
FIG. 1. Genotyping of the cagA variable EPIYA motif. (A) Schematic representation of the cagA variable region. Western CagA (EPIYA-
ABC) is depicted on the top, and East Asian CagA (EPIYA-ABD) is depicted on the bottom. The annealing positions (small arrows), names of
the primers used in this study, and expected sizes (large arrows) of the amplified specific EPIYA motif products as based on the strain K3-CA DNA
sequence are shown. Primer names are abbreviated as follows: cagA28F, A28F; cag2, 2; cagA-P1C, P1C; cagA-pA-1 (R), A; cagA-P2TA, P2TA;
cagA-P2CG, P2CG; cagA-P3E, P3E; and cagA-pD (R), D. (B) PCR amplicons of K49-DU and K3-CA using the forward primer 2 and the reverse
primer A, P2TA and P2CG (equimolar mixture), P3E, or D. “M” designates the size markers (in base pairs). Type indicates the resulting EPIYA
motif identified. (C) Amino acid alignment of the carboxy terminus of CagA from 29 Korean strains carrying the EPIYA-ABD motif. The
EPIYA-A, -B, and -D motifs are indicated below the consensus sequence.
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TABLE 3. Analysis of CagA expression and function
Strain EPIYA motif CagAexpression
Phosphorylation
of CagAa
Induction of
hummingbird phenotypeb IL-8 induction
c
K82-G ABD    
K255-G ABD    
K264-DU ABD    
K111-DU ABD   
K123-G ABD    
K17-CA ABD    
K26-DU ABD    
K208-G ABD    
K21-CA ABD   
K23-DU ABD   
K25-DU ABD   
K42-DU ABD   
K104-CA ABD   
K182-DU ABD   
K193-G ABD   
K238-DU ABD   
K248-G ABD   
K259-CA ABD   
K3-CA ABD  
K6-CA ABD  
K10-CA ABD  
K16-CA ABD  
K19-CA ABD  
K28-DU ABD  
K34-DU ABD  
K35-DU ABD  
K36-DU ABD  
K37-DU ABD  
K41-DU ABD  
K43-DU ABD  
K44-DU ABD  
K45-DU ABD  
K46-DU ABD  
K47-DU ABD  
K48-DU ABD  
K57-G ABD  
K60-G ABC  
K64-G ABCC  
K74-G ABD  
K77-G ABD  
K78-G AABD  
K80-CA ABD  
K85-G BD  
K93-DU ABC  
K107-DU ABD  
K109-G ABD  
K112-G ABD  
K113-G ABD  
K115-G ABC  
K117-G ABD  
K131-G ABD  
K162-G ABD  
K172-G ABCC  
K175-G ABD  
K178-G ABD  
K183-G ABD  
K185-G ABD  
K196-G ABD  
K197-G ABD  
K209-G ABD  
K218-G ABD  
K220-DU ABD  
K223-G ABD  
K235-G ABD  
K241-G ABD  
K258-CA ABD  
K260-CA ABD  
K261-CA ABD  
K262-G ABC  
K263-G ABABDd  
K265-DU ABD  
K266-G ABD  
K24-DU ABD  
K27-DU ABD  
K146-G ABDe  
K154-G ABCCCC  
K165-G ABD  
a , near or above G27-MA (positive control); , slightly below the level of G27-MA; , below the level of G27-MA but above background; , not detectable.
b , greater than 60% of cells displayed the hummingbird phenotype; , less than 60% of cells displayed the hummingbird phenotype.
c , induction was greater than 20-fold more than G27-MA PAI;, induction was 10- to 20-fold more than G27-MA PAI;, induction was less than 10-fold more
than G27-MA PAI.
d Second EPIYA-B motif’s proline is replaced with leucine, ELIYA.
e EPIYA-B motif’s proline is replaced with a serine, ESIYA.
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To confirm the cagA genotyping results, we sequenced the
C-terminal region of the cagA gene from 47 of the 234 geno-
typed strains. These sequences verified that the PCR genotyp-
ing method was accurate. Alignments of the predicted amino
acid sequences of those strains carrying the EPIYA-ABD mo-
tif can be found in Fig. 1C.
Of the 234 genotyped strains, 208 isolates (88.9%) carried an
EPIYA-D motif, therefore classifying them as East Asian, and
26 isolates (11.1%) were determined to carry Western CagA
(see Table S1 in the supplemental material). Among the East
Asian strains, eight carried an incomplete EPIYA-ABD motif
or contained additions of one or more motifs (EPIYA-AABD,
-BD, -BBD, -ABAB*D, and -AB*D, with a mutation within
the EPIYA-B motif designated by an asterisk), and thus, we
subdivided the strains based on the presence of CagA contain-
ing a complete EPIYA-ABD motif versus all other EPIYA
motifs. Given these characteristics, 34 individuals were deter-
mined to have “other genotypes,” which includes alternative
EPIYA-ABD as well as Western motifs.
We next analyzed the distribution of the cagA genotype
among disease states. There were 108 gastritis patients, 54
duodenal ulcer patients, 42 gastric ulcers patients, and 30 gas-
tric cancer patients. EPIYA-ABD CagA composed 80.6% of
gastritis patients, 83.3% of duodenal ulcer patients, 90.5% of
gastric ulcer patients, and 100% of gastric cancer patients.
Stratification of the patients based on age, sex, and disease
categories can be found in Table 1, and a schematic depiction
of the distribution of the cagA genotypes stratified by disease
state within this Korean population can be found in Fig. 2.
Even though this collection was evenly distributed for the
factors of age and gender, several trends for each were ob-
served based on statistical analysis. Not surprisingly, age is
statistically linked to disease state (P  0.001). Moreover, as
has been suggested in other studies (38), males were more
likely to have ulcers (odds ratio, 3.89; confidence interval, 1.81
to 8.36), whereas females were more likely to have gastritis
(odds ratio, 1.91; confidence interval, 1.91 to 5.67). Conversely,
the cancer patients were evenly distributed by gender, with
46.7% being female and 53.3% being male. This differs from
what is most often seen in the H. pylori literature, which shows
that men are anywhere from 1.5 to 2.5 times more likely to be
afflicted with gastric cancer than women (reviewed in reference
35). A significant three-way association was also observed us-
ing log linear modeling between gender, disease, and cagA
allele (P 	 0.009).
Given the fact that 100% of the gastric cancer patients were
infected with H. pylori encoding CagA with the EPIYA-ABD
motif, we conducted statistical analysis to assess the relation-
ship between disease state and genotype. The Fisher exact test
showed that the proportion of patients with the EPIYA-ABD
genotype varied significantly (P 	 0.022) by diagnosis (Fig. 2).
In fact, the proportion of cancer patients with the EPIYA-
ABD genotype (100%) was significantly higher than the pro-
portion with that genotype in gastritis patients (80.6%; P 	
0.004) or duodenal ulcer patients (83.3%; P 	 0.014) but not
gastric ulcer patients (90.5%; P 	 0.109) (Fig. 2). Taken to-
gether, these data suggest that there is a definitive link between
infection with H. pylori strains carrying cagA which encodes the
EPIYA-ABD motif and the development of gastric cancer.
CagA protein expression. Given the fact that we saw a sig-
nificant statistical link between the presence of the EPIYA-
ABD genotype and gastric cancer but that some strains that
carry cagA do not actually express the CagA protein (25), we
next sought to determine if genotypically cagA strains were
phenotypically CagA positive. Bacterial lysates from a subset
of 77 randomly chosen strains were assessed for expression of
CagA. Of the 77 isolates examined using a monoclonal anti-
body, four samples (K19-CA, K82-G, K255-G, and K264-DU)
showed no appreciable CagA expression (Fig. 3A and data not
shown). Given the fact that CagA shows heterogeneity in the
carboxy terminus that may affect protein structure and mono-
clonal antibody recognition, we also utilized a polyclonal anti-
FIG. 2. Schematic depiction of the distribution of the cagA geno-
types stratified by disease state within this Korean population. Distri-
butions of cagA genotypes and EPIYA-ABD versus all other EPIYA
motifs within the four different disease states are shown as follows:
gastritis, gastric ulcers, duodenal ulcers, and cancer. The shaded por-
tion within the other genotypes subgrouping corresponds to the iso-
lates that contain an alternative EPIYA-ABD motif. Calculated P
values, using the Fisher exact test, are shown.
FIG. 3. Expression, delivery, and phosphorylation of CagA.
(A) Western blot analysis of bacterial lysates from the six indicated
Korean strains was conducted using a monoclonal anti-CagA antibody
(top) or the polyclonal anti-CagA antibody b-300 (bottom). (B) Ly-
sates from the bacterial cells alone (BL) and AGS cells infected with
the same bacterial strain (ICL) were assessed for delivery and phos-
phorylation of CagA. Membranes were probed with an anti-phospho-
tyrosine antibody, pY100 (top), stripped, and subsequently reprobed
with the polyclonal anti-CagA antibody b-300 (bottom). Data are
shown from the positive control G27-MA and three indicated Korean
isolates.
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CagA antibody to ensure that CagA was not actually expressed
in these strains. As shown in Fig. 3A, the polyclonal antibody
was better able to detect CagA in the majority of strains. This
included K19-CA, for which CagA was not detected with the
monoclonal antibody. Using this assay, three of the 77 strains
(K82-G, K255-G, and K264-DU) expressed no detectable lev-
els of CagA (Table 3 and data not shown).
Delivery and phosphorylation of CagA. Once CagA is ex-
pressed, it must be delivered to host cells via the type IV
secretion apparatus and phosphorylated by host cell kinases to
be biologically active (40). Therefore, we next conducted phos-
phorylation assays to determine if CagA could be delivered to
and phosphorylated in host cells. Of the 77 strains tested, 59 of
the isolates efficiently delivered CagA to the host cells, as
detected by the appearance of a strongly phosphorylated CagA
band (Fig. 3B and Table 3). Of the remaining 18 isolates, an
intermediate level of phosphorylated CagA was detected for 13
strains, and no detectable phosphorylated CagA was found for
5 strains (K82-G, K111-DU, K123-G, K255-G, and K264-DU)
(Table 3). Importantly, the three strains shown to be negative
for CagA expression were included among these five, and K19-
CA, which was only detected with the polyclonal CagA anti-
body, was positive for phosphorylation.
Cell elongation assay. Upon injection of CagA into host
cells, it becomes phosphorylated and causes striking host cell
elongation, which is known as the hummingbird phenotype
(40). Thus, to reassess the presence of functional CagA in the
18 isolates that produced either an intermediate phenotype or
no detectable level of phosphorylated CagA, the ability to
induce the hummingbird phenotype was assessed in cultured
AGS cells. A wild-type strain, G27-MA, and its isogenic cagA
mutant were used as positive and negative controls, respec-
tively. The percentage of cells displaying the hummingbird
phenotype for the G27-MA cagA-infected cells was 23% and
for the G27-MA-infected cells was 80% (Fig. 4A and B). The
range for the 18 Korean isolates was between 31.5% (K82-G)
and 79% (K25-DU) (Fig. 4C and D; Table 3). Given the large
range of changes, we conservatively required that a strain must
induce at least 60% of AGS cells to display the hummingbird
phenotype to be considered positive for delivery of functional
CagA. Four of the 18 samples tested did not meet this thresh-
old (K82-G, K123-G, K255-G, and K264-DU). These samples
also showed no detectable levels of phosphorylated CagA via
the phosphorylation assay.
Induction of IL-8. Since several isolates were identified that
did not express any detectable level of functional CagA as
measured by the phosphorylation assay and induction of the
hummingbird phenotype, we finally assessed the assembly of
the type IV secretion system on the bacterial surface for this
subset of strains. Proper assembly of the type IV secretion
system has been shown to result in the induction of IL-8 in
cultured AGS cells (10). Therefore, we assessed IL-8 induction
with the four strains that failed to produce phosphorylated
CagA and failed to induce the hummingbird phenotype. Ad-
ditionally, as a positive control, we analyzed several strains that
did induce the hummingbird phenotype. One (K264-DU) out
of the four hummingbird phenotype-negative samples induced
IL-8 (at least 10-fold above the level induced by G27-MA
PAI), indicating that the failure to detect CagA and phos-
phorylated CagA or to induce the hummingbird phenotype was
not impacted by a lack of a functional type IV secretion system
(Fig. 4E and Table 3).
DISCUSSION
Herein, we show a significant statistical link between the
presence of the CagA EPIYA-ABD motif and the develop-
ment of gastric cancer. In fact, 100% of gastric cancer patients
analyzed in this South Korean population were infected with
H. pylori strains encoding CagA containing the EPIYA-ABD
motif. Statistical analysis with the Fisher exact test showed that
the proportion of EPIYA-ABD genotype varied significantly
by diagnosis (P 	 0.022) and that this distribution was statis-
tically different than that of gastritis patients (P 	 0.004) or
duodenal ulcer patients (P 	 0.014) (Fig. 2). These data sug-
gest that the distribution of alleles is not random and is im-
portant in the case of gastric cancer. While on the whole, the
presence of the cagA gene did not strictly correlate to the
expression and delivery of CagA to host cells, all of the ana-
lyzed cancer strains did express a functional CagA that could
be delivered to and phosphorylated in host cells. This is the
first time that a specific cagA allele has been statistically linked
to gastric cancer. However, it should be noted that the EPIYA-
ABD allele is not necessarily a predictor of cancer since there
was a high percentage of peptic ulcer patients, both gastric
(90%) and duodenal (83%), infected with isolates containing
EPIYA-ABD CagA. Alternatively, these data could indicate
that patients infected with H. pylori containing non-EPIYA-
ABD motifs are more likely not to develop cancer.
This association between the East Asian cagA genotype and
gastric cancer may be due to higher affinity for SHP-2 (25).
Binding of CagA with SHP-2 occurs via interaction of the
phosphorylated EPIYA motifs and the SH2 domains from the
host cell protein. This interaction changes the conformation of
SHP-2 to its active form. Thus, the stronger affinity of East
Asian CagA for SHP-2 results in longer periods of SHP-2
activity. This likely explains why East Asian strains cause
greater morphological damage and greater levels of induction
for multiple cellular pathways, resulting in increased prolifer-
ation, morphogenesis, and cell motility compared to those of
Western strains (23–25, 29, 36, 46).
While we did isolate eight EPIYA-AABD, -BD, -BBD,
-ABAB*D, and -AB*D motifs, the vast majority of East Asian
strains that we examined showed strong conservation and a
lack of duplication in the -D region. This suggests that varia-
tion in East Asian cagA is not as favorable as in Western
isolates, where the EPIYA-C motif is found to vary widely
among isolates (4, 6). Similar results have been seen by Argent
et al., who showed by sequence analysis of 
500 East Asian
strains available in GenBank that the percentage of other East
Asian alleles compared to those coding for EPIYA-ABD
CagA was fairly small: 88.3% of East Asian strains contained
an EPIYA-ABD CagA (4). Also, it is interesting that all of the
cancer strains were specifically EPIYA-ABD, which suggests
that among East Asian isolates this combination of EPIYA
motifs is most favored for cancer development. It should be
noted that in a study of Japanese cancer patients, all H. pylori
isolates contained the EPIYA-D motif, and the majority of
those isolates (84%) contained an EPIYA-ABD motif (9).
Alternatively, the other 16% were made up of isolates carrying
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the EPIYA-AABD, -ABBD, -ABABD, and -ABDBD motifs
(9).
The reason for the EPIYA-ABD conservation is unknown,
but perhaps a single EPIYA-D motif allows for optimal SHP-2
binding. The presence of extra motifs may contort CagA’s
conformation and destabilize binding to SHP-2. Additionally,
it is known that CagA phosphorylated at EPIYA-A and -B
motifs binds to Csk, activates a negative feedback loop that
FIG. 4. Morphological changes and induction of IL-8. (A to D) Induction of morphological changes in AGS cells when measured after 9 h of infection with
the following strains: G27-MA (positive control) (A), G27-MA cagA (negative control) (B), K25-DU (C), and K82-G (D). (E) Induction of IL-8 from the
indicated strains expressed as an increase above the induction elicited by G27-MA PAI (negative control) after a 5-hour infection.
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inactivates the Src family kinases, and ultimately reduces the
level of phosphorylated CagA in the cell (45). Thus, it is rea-
sonable to suggest that the presence of additional EPIYA-A or
-B motifs in association with an EPIYA-D motif would more
strongly activate this negative feedback loop (4). In support of
the importance of conservation of the EPIYA-ABD motif in
the disease state, seven out of the eight isolates containing an
EPIYA-D motif but not a complete standard EPIYA-ABD
motif caused only gastritis.
Multiple host, dietary, environmental, and bacterial viru-
lence factors have been shown to play a role in H. pylori-
induced disease. In this molecular epidemiologic study, we
have shown a definitive statistical difference in the distribution
of the cagA allele coding for the EPIYA-ABD motif in cancer
versus other disease states; 100% of the cancer patients were
infected with H. pylori strains carrying the EPIYA-ABD geno-
type. Currently, the reason for this correlation is unclear, and
further study is required to elucidate the molecular role that
the EPIYA motif plays in cancer development.
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